Revolutionizing wound care with modular, inspection-friendly dressings.
Embedded Files
Use of Funds and Market Launch
Use of Funds and Market Launch
ClearikonFLEX™ is designed for frontline healthcare professionals such as in hospitals, clinics, and home health organizations. Clearikon™'s 2026 commercialization strategy will leverage strategic corporate partnerships to tap into established sales and distribution channels immediately.
ClearikonFLEX™ Animal Health is specifically engineered for professional use by veterinarians across clinical, hospital, and farm settings. Clearikon's 2026 market entry strategy leverages a strategic partnership with an established veterinary distributor to immediately tap into existing high-volume sales and distribution channels.
Milestones
Milestones
Human Health
Human Health
•Medical Device Contract Manufacturing - Ongoing
•Simplified Class 1 Bandage FDA Notification Q2-2026
•CMS Reimbursement application July 1 -2026
•Sales Release - Q3-2026
•Distributor sales agreements with hospitals, clinics, and home healthcare Q3-2026
Animal Health
Animal Health
•Medical Device Contract Manufacturing - Ongoing
•Veterinary sales agreements Q1-2026
Capital Request
Capital Request
Series Seed - $2M
Series Seed - $2M
Raise $2M in tranches starting in Q1 2026
Favorable terms on SAFE agreement
Shareholders include founders, friends, and veterinarian
Current shareholders own common stock
Clear Care Products, Inc.
Delaware C Corporation - Incorporated October 2016
Page updated
Report abuse